Navigation Links
aOva Technologies raises $3 million

Madison, Wis. - aOva Technologies, a developer of natural egg protein products, has added $3 million to its nest egg.

aOva recently announced the closing of its latest financing round, which began on March 17 and closed one week ahead of schedule. The funding, collected from various angel investors, will be used by the company to further its l......

Full article >>> aOva Technologies, which was founded in 2001 to commercialize its technology. Lauren Flanagan, chief executive officer of SCIO Corp. and an investor in the company's first round of financing, said aOva Technologies obtained a total of $1.5 million from Continuum Investment, LP, and other investors in its previous round of financing between December of 2004 and February of 2005.

This time,......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 06/19/06


Related biology technology :

1. Merge Technologies net loss doubles to $10.1M
2. Third Wave Technologies to raise $14.9M through private debt
3. Meier joins Broadlook Technologies as COO
4. Platypus Technologies secures $450K SBIR grant
5. Napier joins board of Third Wave Technologies
6. Linda Weber to run Fiservs Interactive Technologies unit
7. Platypus Technologies receives $1.6 million NIH grant
8. UTEK Corp. acquires Xylose Technologies
9. Platypus Technologies receives Phase 2 grant
10. Cedara acquisition costs hit Merge Technologies numbers
11. Platypus Technologies wins another SBIR grant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):